Cryoablation Devices Market Size & Share 2026-2035

Cryoablation Devices Market Size

The global cryoablation devices market was valued at USD 515.3 million in 2025 and is projected to grow from USD 554.2 million in 2026 to USD 1.1 billion by 2035, expanding at a CAGR of 8.3%, according to the latest report published by Global Market Insights Inc.

This substantial growth is driven by numerous factors, such as increasing prevalence of cancer & cardiovascular disorders, growing demand for minimally invasive procedures, and technological advancements in cryoablation devices.

Cryoablation devices are medical systems used to destroy abnormal or diseased tissue by applying extremely low temperatures through specialized probes or catheters. These devices create controlled freezing zones to precisely target tumors or cardiac tissue while preserving surrounding healthy structures. They are widely used in minimally invasive procedures across oncology and cardiology applications.

Leading companies in the market include Medtronic, Boston Scientific, AtriCure, IceCure Medical, and Erbe Elektromedizin. These companies are strengthening their market position by advancing cryoablation technologies across both cardiology and oncology applications. They are focusing on enhancing device precision, improving cryoprobe design, and integrating advanced imaging capabilities to support accurate and efficient treatment delivery.

The market has increased from USD 410.4 million in 2022 and reached USD 477 million in 2024, with a historic growth rate of 7.8%. The increasing prevalence of cancer and cardiovascular disorders is a major driver fueling the growth of the market. As the global burden of chronic diseases rises, there is a growing demand for effective, minimally invasive treatment solutions. According to the American Cancer Society, approximately 2,114,850 new cancer cases are projected to be diagnosed in 2026 in the United States alone, which translates to nearly 5,800 cases per day. This high incidence significantly increases the need for advanced treatment modalities such as cryoablation, particularly for tumors that are difficult to treat with conventional surgery. Additionally, in oncology applications, cardiovascular disorders such as atrial fibrillation are becoming more prevalent due to aging populations, sedentary lifestyles, and increased risk factors like obesity and diabetes. Cryoablation offers precise tissue destruction with minimal damage to surrounding structures, making it an attractive option for both cardiac and oncological procedures. Its advantages, including reduced recovery time, lower complication rates, and repeatability, further support its adoption. Consequently, the growing patient pool requiring safe and effective treatment options continues to accelerate demand for cryoablation devices globally.

Additionally, the growing demand for minimally invasive procedures is a key driver of the market. Patients and healthcare providers are increasingly favoring treatment options that offer reduced surgical trauma, shorter hospital stays, and faster recovery times. Cryoablation aligns well with these preferences, as it enables targeted destruction of abnormal tissues through small incisions, minimizing damage to surrounding healthy structures. This approach is particularly beneficial in treating cancers and cardiovascular conditions, where precision and safety are critical. Additionally, minimally invasive procedures help lower the risk of complications, reduce postoperative pain, and improve overall patient outcomes. Hospitals and outpatient centers are also adopting these techniques to enhance efficiency and reduce healthcare costs. As awareness and acceptance of minimally invasive therapies continue to grow, the demand for advanced cryoablation devices is expected to increase significantly.

Cryoablation Devices Market Trends

• Technological advancements in cryoablation devices are significantly propelling market growth by improving treatment precision and clinical outcomes. Modern systems now incorporate advanced imaging guidance, such as real-time ultrasound, CT, and MRI integration, enabling clinicians to accurately target tumors or abnormal tissues. These developments increase procedural accuracy while minimizing damage to surrounding healthy structures.
• Innovations in probe design and cooling technologies have also enhanced the efficiency of cryoablation procedures. Next-generation cryoprobes offer improved thermal conductivity, faster freezing cycles, and better control over ice ball formation. This allows for more consistent and predictable ablation zones, improving treatment effectiveness across a range of indications, including oncology and cardiology.
• Additionally, the integration of intelligent software and temperature monitoring systems has strengthened procedural safety. These systems provide real-time feedback, allowing physicians to monitor tissue temperature and adjust treatment parameters during the procedure. Such advancements help reduce complications and support improved patient outcomes, making cryoablation a more reliable option.
• Furthermore, portable and user-friendly device designs are expanding the use of cryoablation across various healthcare settings. Enhanced ease of use, along with improved system efficiency, is encouraging wider utilization in hospitals and specialty clinics, thereby contributing to sustained market expansion.

Cryoablation Devices Market Analysis

Based on type, the cryoablation devices industry is bifurcated into probe and systems. The probe segment held the largest share of 72% in 2025.

• Cryoablation probes are essential instruments used to deliver extremely low temperatures directly to targeted tissues, enabling controlled and precise ablation in both oncological and cardiac procedures. These probes are available in various configurations, including different lengths, diameters, and tip designs, allowing clinicians to address a wide range of anatomical and clinical requirements. Technological advancements in probe engineering, such as enhanced thermal conductivity and optimized ice-ball formation, are improving procedural consistency and treatment accuracy.
• Additionally, the integration of advanced materials and design modifications has enabled better maneuverability and improved compatibility with imaging modalities such as CT and ultrasound. The increasing number of cryoablation procedures and the need for multiple probes in a single intervention further support segment growth. The probes segment dominates the market due to its direct application in tissue ablation and recurring procedural usage.
• The systems segment accounted for USD 144.3 million in 2025. Cryoablation systems include consoles, control units, and gas delivery mechanisms that regulate and monitor the ablation process. These systems are responsible for generating and maintaining the required low temperatures, as well as ensuring precise control over freeze-thaw cycles. Modern systems are equipped with advanced software, user-friendly interfaces, and real-time monitoring capabilities to support effective clinical decision-making during procedures.
• Furthermore, the integration of imaging compatibility and temperature feedback systems enhances procedural safety and reliability.

Based on application, the cryoablation devices market is segmented into cardiology, oncology, and other applications. The oncology segment held the largest industry share of 51.5% in 2025.

• The oncology segment involves the use of cryoablation devices for the treatment of various cancers, including liver, kidney, lung, prostate, and breast tumors. Cryoablation provides a targeted approach for tumor destruction by freezing malignant tissues while preserving surrounding healthy structures. This technique is particularly beneficial for patients who are not suitable candidates for conventional surgery, supporting its utilization in both curative and palliative care settings.
• For instance, according to WHO, breast cancer caused an estimated 670,000 deaths globally in 2022 and was the most common cancer in women in 157 countries out of 185 in the same year. 
• The increasing global burden of cancer, along with the preference for minimally invasive and organ-preserving treatment options, is driving the growth of this segment. Continuous advancements in imaging-guided procedures and improved cryoablation systems are further enhancing treatment precision and effectiveness. The oncology segment dominates the market due to the broad range of cancer applications and growing procedural utilization across multiple tumor types.
• The cardiology segment accounted for USD 199.8 million in 2025. The cardiology segment in the market primarily focuses on the treatment of cardiac arrhythmias, particularly atrial fibrillation, through targeted tissue ablation. Cryoablation offers significant clinical advantages in cardiology, including precise lesion formation, reduced risk of damage to surrounding tissues, and improved procedural safety. The technology is widely utilized in electrophysiology procedures, where controlled freezing helps restore normal heart rhythm by interrupting abnormal electrical pathways.

Based on end use, the cryoablation devices market is segmented into hospitals, ambulatory surgical centers, and specialty centers. The hospitals segment held the largest share of 54% in 2025.

• Hospitals represent a primary end user segment for cryoablation devices, driven by the availability of advanced infrastructure, skilled healthcare professionals, and access to comprehensive diagnostic and imaging systems. These facilities are equipped to perform complex cryoablation procedures across oncology and cardiology, including tumor ablation and cardiac arrhythmia treatment. The presence of integrated care pathways and multidisciplinary teams further supports the efficient use of cryoablation technologies in hospital settings.
• Additionally, hospitals handle a high volume of patients requiring minimally invasive procedures, supporting consistent utilization of cryoablation devices. The adoption of advanced surgical technologies, along with increasing investments in healthcare infrastructure, continues to enhance procedural capabilities. The hospitals segment dominates the market due to higher procedure volumes and availability of advanced treatment facilities.
• The ambulatory surgical centers (ASCs) segment is anticipated to grow at a CAGR of 8.8% over the forecast period. Ambulatory surgical centers (ASCs) are gaining traction as an end user segment due to their focus on delivering cost-effective and time-efficient minimally invasive procedures. Cryoablation procedures performed in ASCs benefit from shorter patient stays, streamlined workflows, and reduced operational costs compared to traditional hospital settings. These centers are increasingly equipped with modern medical devices and imaging technologies, enabling them to handle selected cryoablation procedures effectively.
• The specialty centers segment is anticipated to grow at a CAGR of 7.5% over the forecast period. Specialty centers, including oncology clinics and cardiac care centers, play a significant role in the  market by focusing on specific therapeutic areas. These centers are designed to deliver specialized care, often with dedicated expertise in tumor ablation or electrophysiology procedures. The concentration of skilled professionals and targeted treatment approaches enables effective utilization of cryoablation technologies in specialized clinical settings.

North America Cryoablation Devices Market

The North America region accounted for 39.9% of the global market in 2025. The market in North America is experiencing robust expansion.

• The U.S. market was valued at USD 152.7 million and USD 164.1 million in 2022 and 2023, respectively. The market size reached USD 190.3 million in 2025, growing from USD 176.6 million in 2024, and is anticipated to grow at a CAGR of 8% from 2026 to 2035.
• The rising incidence of cancer in North America is a significant factor driving the demand for cryoablation devices. The region continues to report a high number of cancer diagnoses annually, creating a strong need for advanced treatment options. Cryoablation is increasingly preferred for treating tumors due to its precision and minimally invasive nature.
• Additionally, increasing awareness about early diagnosis and treatment has led to higher procedure volumes. Hospitals and cancer care centers are integrating advanced therapies to improve patient outcomes. This ongoing rise in cancer burden is consistently supporting the expansion of the market in North America.

Europe Cryoablation Devices Market

Europe market accounted for USD 130.2 million in 2025.

• The demand for minimally invasive procedures in Europe is rising rapidly, supported by patient preference for quicker recovery and reduced hospital stays. Cryoablation fits well within this trend, offering precise tissue targeting with minimal disruption to surrounding areas. This is encouraging healthcare providers to incorporate such advanced techniques into routine care.
• The increasing prevalence of cardiovascular diseases across Europe is further strengthening the need for effective therapies. Conditions such as atrial fibrillation are becoming more common, particularly among the aging population. Cryoablation provides a reliable option for managing these conditions with fewer complications.
• Additionally, healthcare systems in Europe are focusing on improving treatment efficiency while controlling costs. Minimally invasive techniques like cryoablation help reduce hospitalization expenses and postoperative care needs. This combination of rising disease burden and preference for advanced procedures is significantly supporting market growth.

Asia Pacific Cryoablation Devices Market

The Asia Pacific region is projected to show a lucrative growth of about 8.6% during the forecast period.

• The growing prevalence of cardiovascular diseases in the Asia Pacific region is a key driver for the market. Rapid urbanization, changing lifestyles, and increasing stress levels have led to a surge in heart-related conditions such as arrhythmias and atrial fibrillation. This has heightened the demand for advanced treatment solutions.
• Additionally, the increasing prevalence of cancer in the Asia Pacific region is a major factor driving the market. Countries such as India are witnessing a substantial rise in cancer cases, largely due to population growth, aging demographics, and lifestyle changes. According to the National Institutes of Health (NIH), India recorded approximately 1,461,427 new cancer cases in 2022, highlighting the growing burden of the disease across the region.
• Moreover, improving healthcare infrastructure and access to specialized cardiac treatments are encouraging the use of advanced procedures. As the burden of cardiovascular diseases continues to rise, healthcare providers are increasingly utilizing innovative technologies like cryoablation to manage patient outcomes effectively, boosting market growth.

Latin America Cryoablation Devices Market 

The Latin America market is experiencing robust growth over the analysis timeframe.

• Technological advancements in cryoablation devices are playing a crucial role in driving the market in Latin America. Improvements in imaging integration, such as real-time ultrasound and CT guidance, are enabling more accurate targeting of diseased tissues. This has enhanced treatment precision and increased confidence among healthcare professionals.
• Developments in cryoprobe design and cooling efficiency have further improved procedural outcomes. Advanced probes allow better control of freezing zones and ensure more consistent ablation results. These innovations are making cryoablation suitable for treating a wider range of conditions, including oncology and cardiology applications.
• Moreover, the availability of user-friendly and portable systems is supporting greater utilization across healthcare facilities. As medical centers adopt these improved technologies, treatment capabilities expand, leading to better patient outcomes. Such advancements are steadily strengthening the growth of the market in the region.

Middle East and Africa Cryoablation Devices Market 

The Middle East and Africa (MEA) market is expected to witness lucrative growth opportunities during the forecast period.

• Rising government initiatives in Saudi Arabia are significantly contributing to the growth of the market. The government is investing heavily in healthcare infrastructure under Vision 2030, focusing on enhancing access to advanced medical technologies. This is encouraging the integration of innovative treatments such as cryoablation.
• Additionally, various awareness campaigns are being conducted to promote early diagnosis and effective management of chronic diseases. Increased public awareness about cancer and cardiovascular conditions is leading to higher screening rates and demand for advanced treatment options. Cryoablation is gaining attention as a safe and efficient solution.

Cryoablation Devices Market Share

• The top five players, Medtronic, Boston Scientific, AtriCure, IceCure Medical, and Erbe Elektromedizin, collectively accounted for approximately 65% share of the market, driven by strong product portfolios, advanced cryoablation technologies, extensive clinical utilization, and strategic collaborations across hospitals and specialty care centers to enhance treatment outcomes in oncology and cardiology applications.
• Cryoablation device manufacturers, medical technology providers, and research institutions are increasingly focusing on technological improvements to enhance procedural accuracy, treatment efficiency, and patient outcomes. Key areas of development include advanced imaging integration, such as real-time ultrasound, CT, and MRI guidance for precise targeting of tissues. In addition, innovations in cryoprobe design, temperature monitoring systems, and improved cooling mechanisms enable better control over ablation zones. Continuous investments in high-performance systems, device miniaturization, and improved data integration technologies are supporting efficient deployment across hospitals, specialty clinics, and ambulatory surgical centers.
• Market participants, including device manufacturers, healthcare providers, and research organizations, are actively strengthening strategic collaborations to expand the clinical application of cryoablation devices. Partnerships with hospitals and specialized treatment centers are improving procedural expertise and increasing access to advanced therapies. Furthermore, collaborations with academic and clinical research institutions support innovation in treatment applications such as oncology and cardiology. These initiatives are enhancing treatment accessibility, streamlining clinical workflows, and supporting wider utilization of cryoablation procedures across diverse healthcare settings, thereby contributing to overall market growth.

Cryoablation Devices Market Companies

Few of the prominent players operating in the cryoablation devices industry include:

• Adagio Medical
• AtriCure Inc.
• Boston Scientific
• CooperSurgical
• CPSI Biotech
• Endocare (HealthTronics)
• Erbe Elektromedizin
• Hygea Medical
• IceCure Medical
• Inomed Medizintechnik
• Medtronic
• Monteris Medical
• METRUM Cryoflex
• Varian Medical Systems
• IceSense Medical

• IceCure Medical

IceCure Medical strengthens its footprint with liquid nitrogen-based cryoablation systems, driven by growing use in breast tumor treatments, office-based procedures, and emphasis on cost-effective, minimally invasive oncology solutions.

• Erbe Elektromedizin

Erbe Elektromedizin expands its market reach through reliable cryoablation and surgical energy systems, supported by a strong presence in Europe, integration across multiple clinical specialties, and a focus on safe and precise tissue ablation technologies.

Cryoablation Devices Industry News

• In February 2022, Medtronic plc received approval for its Freezor and Freezor Xtra cardiac cryoablation catheters from the U.S. FDA to treat pediatric patients suffering from atrioventricular nodal re-entrant tachycardia. This strategy broadened the company’s customer base, thereby augmenting its business revenue size.

The cryoablation devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Probe
  • Tissue contacts probe ablators
  • Epidermal and subcutaneous cryoablation systems
  • Tissue spray probe ablators
• Systems
  • Generator
  • Accessories & consumables

Market, By Application

• Cardiology
• Oncology
  • Lung cancer
  • Breast cancer
  • Liver cancer
  • Kidney cancer
  • Prostate cancer
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Specialty centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE